Residency Program Director

Contact Information:
mdonnelley@ucdavis.edu 
Office: 916-703-4026
UC Davis Health
Pharmacy Department
2315 Stockton Blvd, Room 1310
Sacramento, CA 95817

Monica Donnelley, Pharm.D, BCIDP, BCPS AQ-ID, AAHIVP 
Senior Pharmacist
UCDH Infectious Diseases
Assistant Professor,
UCSF School of Pharmacy
UCD School of Medicine
Touro University, College of Pharmacy

2020-2021 Resident:
Helen Berhane, Pharm.D.
Jason Chao, Pharm.D.

ASHP Residency Listing:
https://accred.ashp.org/aps/pages/directory/residencyProgramInformation.aspx?ID=63590

UC Davis Health PGY2 Infectious Diseases Residency Purpose

The PGY2 Infectious Diseases Residency Program builds on the Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency program to contribute to the development of a clinical pharmacist in a specialized area of practice. The residency provides the resident(s) with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete the accredited PGY2 in ID pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification in infectious diseases (BCIDP).

UCDH PGY2 Infectious Diseases Residency Purpose

The PGY2 Infectious Diseases Residency Program builds on the Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency program to contribute to the development of a clinical pharmacist in a specialized area of practice. The residency provides the resident(s) with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete the accredited PGY2 in ID pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification in infectious diseases (BCIDP).

Resident Testimonial

“For me, the first thing that always attracts me to a program are the people in it. I had the pleasure of first meeting our residency program director, Dr. Monica Donnelley, as the professor for many of the infectious diseases lectures I had during pharmacy school. Many of these lectures, from spectrum of activity to tuberculosis, were what initially piqued my rapidly growing interest in infectious diseases to begin with. Throughout my interactions with her over the following years, I learned not only how brilliant she was as a professor and clinician, but also how amazing she was as a person: welcoming, nurturing, vibrant, down to earth. As I started to meet more members of the UCDH family, I realized why Dr. Donnelley had been there since she first started her career; because everyone was infectiously amicable, creative, and just genuinely enjoyable to be around. I was drawn to UCDH. I never had a choice.”
–Jason Chao, 2020-2021 Resident

Program Overview

The Post Graduate Year Two (PGY2) Infectious Diseases Residency at UC Davis Health (UCDH) is designed to provide PGY1 graduates the opportunity to accelerate growth beyond generalist practice and further the development of specialized care in areas specific to the needs of infectious diseases patients. It is assumed that the resident has already achieved a basic level of competence commensurate with that of a PGY1 Pharmacy Practice Residency. The PGY2 residency focuses on developing the knowledge, attitudes, training and skills necessary to cultivate pharmacists who are competent and compassionate practitioners who are prepared for a role as an infectious diseases pharmacist.

Graduates of the residency are prepared to design, implement, and/or enhance an institutional antimicrobial stewardship program, serve as an infectious diseases clinical pharmacist in the areas of: infectious diseases consult service, infectious diseases transplant service, pediatric infectious diseases consult service. Graduates gain experience in additional areas of infectious diseases such as HIV, hepatitis, burn, intensive care, microbiology and new diagnostics.  Research opportunities may include: clinical trials, epidemiology of antimicrobial resistance, outcome studies, and antibiotic utilization studies. The resident’s research will be presented at a major pharmacy or infectious diseases meeting. Teaching opportunities include precepting UC San Francisco, School of Pharmacy students spending their 4th year at UC Davis, participation in the annual UC Davis Infectious Diseases Continuing Medical Education Conference, and additional opportunities available at the UCDH and area pharmacy schools if desired.

Completion of this PGY2 Infectious Diseases Residency will provide the practitioner the advanced critical thinking skills and clinical knowledge necessary to practice as an infectious diseases pharmacotherapy expert, to serve as an antimicrobial subcommittee coordinator, and/or to share skills with others by serving as an college of pharmacy faculty member. The graduate of this program will qualify to take the board certification in infectious diseases exam (BCIDP).

Although the primary goal of the residency is listed above, there are options for emphasis in this residency program. The resident may choose emphasize in academia. Academia emphasis would include experiences with faculty from the UCSF School of Pharmacy and extended time as primary preceptor for students and residents in infectious diseases. Opportunities to give formal lectures at Touro University, College of Pharmacy can be scheduled and other area pharmacy schools if desired.

Day in the Life of an Infectious Diseases Resident

UCDH’s comprehensive residency experience starts with the layered learning model. PGY2 ID residents often serve as the first point of contact for ID pharmacy questions to pharmacy students, PGY1 pharmacy residents, medical students, medical residents, and ID fellows. Until ID consult rounds start, I am balancing my patient workup with answering drug information questions or antibiotic recommendations/approvals from physicians. I also address any questions from pharmacy learners regarding rapid blood culture PCR test results (Biofire) or antibiotic therapeutic drug monitoring (TDM) on antimicrobials with narrow therapeutic indices, such as vancomycin or aminoglycosides, which we monitor daily to ensure patients are on appropriate therapy. After rounds, I am following up with the primary medicine team’s pharmacist or physicians to ensure ID consult recommendations are implemented as intended, continuing to monitor test results or TDM as needed, or participating in topic discussions with other pharmacy or medical learners. Of course, throughout the day I always have several ID pharmacists only a desk away, readily available as a resource when I am stumped. Lastly, we participate in weekly ID department wide journal clubs and case conferences, where we are constantly updated with the most recent literature, exposed to unique or complex patient cases, and given insight into the perspective of a multitude of teaching-oriented providers.

UCDH and Pharmacy Services

UCDH is a major academic health center located in Sacramento, California. Pharmacy services recruits, hires and trains caregivers to provide progressive pharmacy services as collaborative team members to support optimal patient outcomes.

More about the Department can be found on our Webpage: https://www.ucdmc.ucdavis.edu/pharmacy

Program Design:

The UCDH PGY2 Infectious Diseases Residency is designed to meet the educational goals and objectives, as outlined by the ASHP PGY2 Infectious Diseases Accreditation Standard.

Educational Outcomes Required by the Accreditation Standard:

R1. Patient Care
R2. Advancing Practice and Improving Patient Care
R3. Leadership and Management
R4. Teaching, Education, and Dissemination of Knowledge
Electives may be added based on available resources and resident interest

Outcome R1: Patient Care
In collaboration with the health care team, provide comprehensive medication management to patients with infectious diseases following a consistent patient care process. Ensure continuity of care during infectious diseases patient transitions between care settings. Manage antimicrobial stewardship activities.

Outcome R2: Advancing Practice and Improving Patient Care
Demonstrate ability to manage formulary and medication-use processes for infectious diseases patients, as applicable to the organization and antimicrobial stewardship program. Demonstrate ability to conduct a quality improvement or research project. Manage and improve anti-infective-use processes.

Outcome R3: Leadership and Management
Establish oneself as an organizational expert for infectious diseases pharmacy-related information and resources. Demonstrate leadership skills for successful self-development in the provision of care for infectious diseases patients. Demonstrate management skills in the provision of care for infectious diseases patients.

Outcome R4: Teaching, Education, and Dissemination of Knowledge
|
Provide effective medication and practice-related education to infectious diseases patients, caregivers, health care professionals, students, and the public (individuals and groups). Effectively employ appropriate preceptor roles when engaged in teaching students, pharmacy technicians, or fellow health care professionals) about care of patients with infectious diseases.

This residency will offer the resident the opportunity to rotate on several infectious diseases consult services and work with various disease states. Patient care is provided in multidisciplinary settings, specifically our Outpatient Parenteral Antimicrobial Program (OPAT) and ambulatory care clinics such as infectious diseases clinic, HIV, hepatitis, travel clinic. The resident will interact with clinical pharmacists, physicians, nurses, discharge planners, microbiologist, molecular department, patients, and caregivers to provide comprehensive care to patients in with infectious diseases. Daily activities will include seeing patients, providing phone based support for transition of care discharge of patients leaving the hospital on intravenous antimicrobial agents, reviewing existing policies and guidelines for appropriateness, and creating new resources to assist in the care of patients. The infectious diseases resident will be expected to be proficient at working with the infectious diseases consults service and the OPAT program and as their contribution to the institution in the form of service, will be expected to work as a pharmacist in that setting in order to understand firsthand the best way to implement policies/procedures that affect staff and to provide professional growth.  Residents and RPD’s will determine the rotational opportunities and target areas for growth as the residency progresses.

Program Structure

The PGY2 Infectious Diseases Residency is a full-time, one-year commitment, beginning on July 1st and ending on June 30th, unless alternative dates are pre-arranged.  Clearance to start work by UCDH Employee Health and a Human Resources orientation meeting must be completed prior to July 1st.

Proposed Calendar of Activities:

Quarter 1

Quarter 2

Quarter 3

Quarter 4

July

  • Orientation/training
  • Entering assessment
  • Establish residency goals/customized learning plan
  • Selection of research project topic
  • Clinical rotation: Inpatient Adult ID Consult Service Rotation Part I

October

  • Clinical rotation
  • Conduct research
  • Start residency recruitment for the following year

January

  • Clinical or Elective rotation
  • Residency candidate interviews

April

  • Clinical rotation: Adult ID Consult Service Part II primary preceptor
  • UC Collaborative Research Conference
  • Abstract submission to ICAAC or IDSA

August

  • Preparation of research protocol
  • Clinical rotation: Microbiology Lab

November

  • ASHP Midyear Clinical Meeting
  • Conduct research

February

  • Clinical or Elective rotation
  • Compile research project results and prepare draft presentation to RPD

May

  • Clinical or Elective rotation

September

  • Clinical rotation
  • Attend IDSA Meeting: ID Week
  • IRB submission of research project
  • Quarterly development plan
  • Pharmacy Week event

December

  • Clinical rotation
  • Quarterly development plan
  • Review residency candidate packets
  • Annual UCDH Infectious Diseases Conference Medical CE presentation

March

  • Clinical or Elective rotation
  • Research project deliverables
  • Quarterly development plan

June

  • Block of ID Pharmacist service
  • End of residency closeout and program improvement evaluation
  • Residency Requirements checklist completed

Longitudinal Activities

  • Competency Training
  • Journal Club with the infectious diseases division, attend every Tuesday, present at minimum two articles
  • Case conference with the infectious diseases division attend every Friday
  • Administrative guidelines and policies: review one of each and create one if needed
  • Appendix of Therapeutic Areas of Practice
  • Committee assignments: Antibiotic Subcommittee, Antimicrobial Stewardship Workgroup, Infection Prevention Committee, and others available to join that align with the resident’s interest
  • Attend monthly ID pharmacy meetings
  • Teaching Certificate Program (if not completed during PGY1)
  • Research project
  • Mentorship program
  • Professional Society Involvement, encourage joining SIDP and or IDSA
  • Service requirements

UCDH PGY2 Infectious Diseases Residency Learning Experiences:

The residency learning experiences will primarily be divided into block rotations and longitudinal learning experiences.  The majority of rotations will be 4 weeks in duration.  Rotation schedules will be determined based on availability and resident interests, and will be designed to include all required CAGOs as well as a variety of clinical experiences and environments.  A minimum of 8 months will be spent in direct patient care experiences. Rotation schedules will be adjusted and updated quarterly, in conjunction with preparing the updated development plan.


Required Learning Experiences

Type of Experience

Overview

Orientation/training

Concentrated (3 days) Orientation to UCDH and PGY2 Infectious Diseases residency program.  Duration may be adjusted, based on the resident’s previous experience and knowledge of UCDH.

Research and Scholarship

Longitudinal (12 months) The resident will be expected to complete a project selected and agreed upon by the resident and RPD. Attention to the deliverables set forth by the Pharmacy Research Oversight Committee (PROC) facilitates successful completion of the project.

Teaching

Longitudinal (12 months) The resident will serve in the layer learning model as a mentor and preceptor to PGY1 residents and pharmacy interns while on rotation. The resident will have opportunities to deliver a didactic lecture(s). The resident is expected to complete the teaching certificate offered at UCDH if not completed during their PGY1 year at UCDH or an equivalent teaching certificate elsewhere.

Infectious Diseases Consult Service
Part I and II

Two Blocks (12 months) The infectious diseases consult service rotation will be a two part rotation. Part I the resident will become familiar with the consult service, team members, and facilitate the care of patients with infections diseases. For Part II of the rotation the resident will serve as the primary preceptor for two 4th year pharmacy interns and facilitate the care of the patients on the service

Infectious Diseases Transplant Service

Block
(4 weeks)
The focus of this rotation is working with the ID transplant service and the immune compromised populations. The two main populations encountered will be solid organ transplant patients and bone marrow transplant patients. A heart transplant program is under development and although we do not preform other transplants such as lung or liver, we do care for these patients pre and post transplantation.
Infectious Diseases Pediatric Consult Service Block
(4 weeks)
UCDH has a children’s hospital located within the main hospital. The resident will have the opportunity to round with dedicated pediatric ID attendings and medical learners. In addition to the consult service the resident will have exposure to the pediatric clinic and a very robust and advanced pediatric handshake stewardship service. Infection prevention rounds are also part of this rotation.
Service Requirements Longitudinal
(12 months)
The resident will provide infectious diseases focused service to the institution every third weekend of the residency year.  Service will include rounding with the ID consult service, providing support to the OPAT program, assisting other clinical pharmacists with ID related cases and antimicrobial monitoring an stewardship.
Microbiology Block
(2 weeks)
Our microbiology department is also a training facility for clinical scientists and they are wonderful teachers. During this rotation the resident will move through the various “benches” to become familiar with specimen processing, time it takes to get results, what is considered pathogenic vs contamination. Starting at intake and then move through the blood bench, respiratory bench, urine, anaerobes, CSF, C. diff, molecular tests, fungal/mycology. We have BioFire being set up and are running MALDI-TOF, Phoenix, a meningitis encephalitis panels, and continuously adding new diagnostic tools.
Antimicrobial Stewardship Block
(8 weeks)
The antimicrobial stewardship program (ASP) consists of an ID-trained pharmacist and ID physician at minimum and may include an ID fellow.  The program’s goals are to improve outcomes for patients with infectious diseases, optimize selection/dosing/duration of antimicrobial therapy, prevent emergence of antimicrobial resistance, reduce C. difficile-associated infection rates, and prevent adverse effects related to antimicrobials.
HIV Block
(4 weeks)
The resident is provided a 4 week rotation in the HIV Ambulatory Care clinic. During this rotation the resident will actively participate in the treatment of patients at the One Community Health (OCH) Clinic, specifically seeing patients for HIV comprehensive care, MTM Services, Hepatitis C treatment, adherence support and management of other infectious disease related health conditions. The resident will be available for drug information requests from attending physicians, nurses, and other health care providers at any time. The resident will assume the role of co-preceptor for pharmacy interns and will lead infection related disease state discussions with the interns.

Elective Learning Experiences

Type of Experience

Overview

International Rotation

Block
(2 weeks)
Residents who choose to participate will be offered a chance to provide pharmaceutical care to patients during a Medical Mission trip

Burn

Block
(4 weeks)
The Burn Surgery experience provides the PGY2 ID resident with the opportunity to participate in the care of unique patient populations with life-threatening burn injuries and severe cutaneous adverse reactions.  Burn survivors tend to be younger, subject to fewer baseline co-morbidities, and more likely to have a history of substance abuse and/or mental illness.  Initially, the patient-specific problems and challenges are related to the unique type of injury experienced, but patients rapidly develop the common complications of critical illness.

ICU: MICU/SICU

Block
(4 weeks)
The resident will focus on patients with infectious diseases in the critical care setting. The SICU or MICU depending on interest and previous experience. Appropriate dosing, PK/PD alterations and sepsis will be emphasized during the rotations.

Hep C

Block
(4 weeks)
The resident is provided a 4 week rotation in the Hep C Ambulatory Care clinic. During this rotation the resident will actively participate in the treatment of patients at the One Community Health (OCH) Clinic, specifically seeing patients for Hepatitis C treatment. The resident will be available for drug information requests from attending physicians, nurses, and other health care providers at any time. The resident will assume the role of co-preceptor for pharmacy interns and will lead ID related disease state discussions with the interns.

Investigational Drugs

Block
(4 weeks)
The IDSA’s 10 x ’20 initiative seeks a global commitment to produce 10 new systemic antibiotics by the year 2020. This commitment to research and development means that there are new and exciting clinical trials for these agents in development. The UCDH Investigational Drugs Service manages investigational drugs for over 200 active clinical trials including trials on new antibacterial agents, new antifungal agents and new agents to treat HIV and Hep C. The main intent of the Investigational Drugs Service rotation for the PGY2 Infectious Disease resident is to allow the resident to gain experience in the procurement, distribution and administration of investigational drugs to patients with infectious diseases.  Additionally, the resident will be exposed to the administrative and regulatory processes involved in evaluating, approving and managing investigational drug protocols in an academic institution.  Successful completion of this rotation will contribute to the PGY2 Infectious Disease resident accomplishing the required educational.

Nephrology

Block
(2 weeks)
During the Nephrology learning experience, the resident will be exposed to the nephrology consult service and familiarize them self on the process of managing renal impairment use of renal support therapies and principles for drug dosing adjustments.

UCDH PGY2 Infectious Diseases Resident’s Role in Teaching:
UCDH offers many opportunities for both clinical and didactic teaching. The resident will be responsible for assisting preceptors with clerkship teaching for University of California, San Francisco pharmacy students, University of the Pacific pharmacy students and UCDH PGY1 pharmacy residents.  The resident will assume the primary preceptor role for UCSF pharmacy students during their rotations in the latter part of the residency.

The resident will be required to prepare an ACPE accredited pharmacy grand rounds presentation or department competency on an infectious diseases-based topic, based on the resident’s interests and a department needs assessment.  In addition, the PGY2 Infectious Diseases Resident may choose to participate in academic teaching, as requested by regional schools of pharmacy, with the approval of the PGY2 Infectious Diseases Residency Director.

Residency Research Project:
All UCDH PGY2 residents are required to complete a research project and present their research in a podium presentation at the UC Collaborative Conference or other Regional meeting.  In preparation for conducting their research project, the resident will be complete UCDH IRB-required training and certification.  The resident will prepare a project proposal, which will be reviewed and approved by the UCDMC Pharmacy Residency Oversight Committee (PROC).  The resident will also submit their project to the Pharmacy and Therapeutics Committee. They will submit to IRB for review, before embarking on their research.  Upon completion of the project, the resident will be required to summarize their research project for the Departmental newsletter and prepare a manuscript. PGY2 residents will be required to submit their manuscript for publication and to prepare an electronic poster suitable for submission.

Committee Assignments:
The PGY2 Infectious Diseases resident will participate in various committee activities, as assigned by the PGY2 Infectious Diseases residency director.  Assignments will be determined based on current department initiatives.  The purpose of the resident’s committee involvement is to ensure the resident gains exposure to the infectious diseases pharmacists role in activities related to quality-improvement, medication safety, safe handling of hazardous drugs, guideline development and assessment/implementation of technology and automation within the institution and pharmacy department.  Committees in which the infectious diseases pharmacists play a key role at UCDH include:  Antibiotic Subcommittee Meeting, Pharmacy and Therapeutics committee, Infection Prevention, Sepsis, Antimicrobial Stewardship, and their various quality improvement groups.

Professional Development:
The PGY2 Infectious Diseases resident is encouraged to maintain an active role in pharmacy professional organizations.  The resident is strongly encouraged to become a member of the Society of Infectious Diseases Pharmacists (SIDP), American Society of Health Systems Pharmacists (ASHP) and the American College of Clinical Pharmacists (ACCP) and attend their annual meetings. The resident will be provided with some financial support from the institution and professional leave time to facilitate participation in professional development activities.

Pharmacy Department Service:
The PGY2 Infectious Diseases resident will be expected to provide pharmacy department service hours. The service requirement is clinical and operational support for the OPAT program, providing monitoring of antimicrobials to hospitalized patients, and antimicrobial stewardship every 3rd weekend and 1 major holiday. Additionally, residents may occasionally be called upon to provide clinical staff coverage for the clinical service that that they are currently serving on rotation, as well as staffing some evenings to support inpatient clinical services. A back-up ID pharmacist or the Residency Program Director will always be available on site or on-call, to advise and support the PGY2 ID resident as needed. It is anticipated that the PGY2 resident will offset a staff pharmacist in a clinical setting, once competency is established.

Required Competencies:
Residents function as licensed pharmacist’s in patient care activities. As such, minimum knowledge in a variety of areas must be assured. Within one month of starting the Residency, the resident must complete competencies required of all clinical pharmacists. Basic Cardiac Life Support (BCLS) and Advanced Cardiac Life Support (ACLS) certification is required.

Resident Portfolio:
Each resident must maintain a portfolio containing all information from the residency year including yet not limited to: copies of papers or projects done during rotations, lectures given, research project manuscript, P&T drug monograph, and MUE. The portfolio shall be maintained in Pharm Academic.

Sick Leave:
Residents have 6 days of extended sick leave. Use of sick leave is subject to approval by the RPD consistent with Medical House Staff Policies and Procedures.

Vacation, Holidays and Professional Leave:
Residents have 21 days of Paid Time Off (PTO) and 4 days for Professional Development. Travel Funds: $2,500 included in base salary. Use of leave must be arranged in advance with the RPD.

Resident Personnel Policies:
The following policies can be located in the Pharmacy Resident Personnel Manual located at https://hr.ucdavis.edu/employees/ucdh-resident

  • Resident Qualifications
  • Early Commitment Policy
  • Pre-employment drug testing
  • Health insurance and Benefits
  • Licensure requirement for 2/3 of the residency year
  • Moonlighting
  • Duty hours
  • Tracking of duty hours
  • Professional, family, and extended leave policies
  • Dismissal policy and consequences of failure to progress

Requirements for successful completion of the residency:

  • California license obtained per residency policy
  • Successful completion of all required learning experiences and associated assignments
  • Successful completion of all required rotations/learning experiences with no outstanding ‘Needs Improvement’ on any required rotation goals or objectives and a minimum of 80% reaching ‘Achieved’ by the end of the residency year
  • Completion of a research project
  • Presentation of research project at UC Collaborative Conference (or equivalent)
  • Preparation of manuscript and/or poster for research project, submit for publication
  • Completed staffing requirements as outlined by the residency program description
  • Pharmacy Grand Rounds and Pharmacy competency presentation
  • Completion of the PGY-2 Infectious Diseases State Appendix to the minimum standard
  • Completed end-of-year self-assessment and residency program assessment
  • Resident closeout completed in Pharm Academic with portfolio attachments uploaded
  • A minimum of 12 months training inclusive of standard vacation, professional and sick leave